![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ABHD11-AS1 |
Gene summary for ABHD11-AS1 |
![]() |
Gene information | Species | Human | Gene symbol | ABHD11-AS1 | Gene ID | 171022 |
Gene name | ABHD11 antisense RNA 1 (tail to tail) | |
Gene Alias | LINC00035 | |
Cytomap | 7q11.23 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
171022 | ABHD11-AS1 | P22T-E | Human | Esophagus | ESCC | 7.43e-03 | 7.46e-02 | 0.1236 |
171022 | ABHD11-AS1 | P37T-E | Human | Esophagus | ESCC | 5.00e-02 | 7.14e-02 | 0.1371 |
171022 | ABHD11-AS1 | P39T-E | Human | Esophagus | ESCC | 4.56e-04 | 1.50e-01 | 0.0894 |
171022 | ABHD11-AS1 | P75T-E | Human | Esophagus | ESCC | 9.95e-04 | 1.19e-01 | 0.1125 |
171022 | ABHD11-AS1 | P82T-E | Human | Esophagus | ESCC | 1.81e-11 | 8.13e-01 | 0.1072 |
171022 | ABHD11-AS1 | P128T-E | Human | Esophagus | ESCC | 7.64e-11 | 5.75e-01 | 0.1241 |
171022 | ABHD11-AS1 | P130T-E | Human | Esophagus | ESCC | 1.66e-02 | 8.64e-02 | 0.1676 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |